Auna's preliminary Q3 results reveal an 11.7% year-over-year increase in surgeries across Peru, Colombia, and Mexico, driven by higher hospital occupancy and expanded oncology services. Contractual price adjustments also support expectations for EBITDA margin recovery by the second half of 2026. Trading at about 4.5x forward EV/EBITDA, below its historical average, Auna's improving free cash flow could enable further debt reduction. The company is rated Strong Buy due to double-digit revenue growth, improving profitability, and potential valuation gains.
Auna's recent performance in hospital volumes and valuation is notable. For readers following the health sector, here is Pluang's market snapshot as of Oct 21, 2026 08:02 WIB: out of 150 priced health-sector US stocks, 132 rose and 18 fell. Among notable movers, SYRE rose 8.30% to USD 91.75 with a typical hold time of 2 days, NUVB increased 8.04% to USD 4.84, and TDOC declined 8.03% to USD 6.19 with a typical hold time of 39 days.
HUTCHMED has finalized an exclusive license agreement with GSK granting GSK rights to develop and commercialize HMPL-A830, a novel KRAS-EGFR antibody conjugate therapy, outside China, Hong Kong, Macau, and Taiwan. This therapy targets cancers with KR...
Medical Informatics Corp. has launched the Sickbay Experience Demo Center at Texas Medical Center's Helix Park, showcasing its FDA-cleared Sickbay platform. This interactive center demonstrates how real-time patient data from various medical devices ...
Closed-end funds can trade at prices significantly different from their net asset value, creating opportunities for investors to buy at discounts. This article highlights two such funds that provide unique investment exposure and may see their discou...
Actinogen Medical has entered 'database lock' for its XanaMIA Alzheimer's trial, finalizing data collection from 247 patients to analyze the effects of its drug Xanamem. The 36-week trial tested Xanamem's ability to slow Alzheimer's progression by co...
Canton Coin (CC) dropped 16% over seven days, closing near $0.10 on Oct. 20, down from $0.125 on Oct. 13. This decline comes as The Depository Trust Company (DTC) prepares to launch a tokenization service linked to the Canton Network, expected in Q4 ...
